Integrating the environmental and genetic architectures of aging and mortality.
Argentieri MA. et al, (2025), Nat Med
Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank.
Collister JA. et al, (2024), Cancer Epidemiol Biomarkers Prev, 33, 812 - 820
Incorporating polygenic risk into the Leicester Risk Assessment score for 10-year risk prediction of type 2 diabetes.
Liu X. et al, (2024), Diabetes Metab Syndr, 18
Assessing the importance of primary care diagnoses in the UK Biobank.
Clifton L. et al, (2024), Eur J Epidemiol, 39, 219 - 229
Association between metabolic syndrome and risk of incident dementia in UK Biobank.
Qureshi D. et al, (2024), Alzheimers Dement, 20, 447 - 458
Independent external validation of the QRISK3 cardiovascular disease risk prediction model using UK Biobank.
Parsons RE. et al, (2023), Heart, 109, 1690 - 1697
Kidney function, albuminuria, and their modification by genetic factors and risk of incident dementia in UK Biobank.
Yeh T-S. et al, (2023), Alzheimers Res Ther, 15
Polygenic Risk of Prediabetes, Undiagnosed Diabetes, and Incident Type 2 Diabetes Stratified by Diabetes Risk Factors.
Liu X. et al, (2023), J Endocr Soc, 7
Hypertension, a dementia polygenic risk score, APOE genotype, and incident dementia.
Littlejohns TJ. et al, (2023), Alzheimers Dement, 19, 467 - 476
Integrating the environmental and genetic architectures of mortality and aging
Argentieri A. et al, (2023)
Assessing agreement between different polygenic risk scores in the UK Biobank.
Clifton L. et al, (2022), Sci Rep, 12
Assessing agreement between different polygenic risk scores in the UK Biobank
Clifton L. et al, (2022)
Calculating Polygenic Risk Scores (PRS) in UK Biobank: A Practical Guide for Epidemiologists.
Collister JA. et al, (2022), Front Genet, 13
Are polygenic risk scores for systolic blood pressure and LDL-cholesterol associated with treatment effectiveness, and clinical outcomes among those on treatment?
Tapela NM. et al, (2021), Eur J Prev Cardiol
Prevalence and determinants of hypertension control among almost 100 000 treated adults in the UK.
Tapela N. et al, (2021), Open Heart, 8